Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Haese

Showing results (161-170 of 214) with videos related to

Pageof 22
Sort By:
BJU International|April 13, 2007
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancerAndrea Gallina, Pierre I Karakiewicz, Felix K-H Chun, et al.
Plos One|August 1, 2015
High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate CancerNathaniel Melling, Levon Harutyunyan, Claudia Hube-Magg, et al.
BJU International|August 19, 2014
Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre European prospective studyAlberto Abrate, Massimo Lazzeri, Giovanni Lughezzani, et al.
BJU International|October 13, 2006
Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patientsFelix K-H Chun, Alberto Briganti, Elie Antebi, et al.
European Urology|October 3, 2006
Development and external validation of an extended 10-core biopsy nomogramFelix K-H Chun, Alberto Briganti, Markus Graefen, et al.
European Urology|September 20, 2015
Safer Surgery by Learning from Complications: A Focus on Robotic Prostate SurgeryRené J Sotelo, Alexander Haese, Victor Machuca, et al.
Cancer Biology & Medicine|February 25, 2021
Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancerAndreas Marx, Lena Koopmann, Doris Höflmayer, et al.
BJU International|September 16, 2009
Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancerHendrik Isbarn, Pierre I Karakiewicz, Sascha A Ahyai, et al.
European Urology|October 4, 2025
Best Systemic Therapy With or Without Radical Prostatectomy in the Management of Men With Oligometastatic Prostate Cancer: The RAMPP Randomised Controlled TrialMarkus Graefen, Fabian Falkenbach, Tobias Maurer, et al.
European Urology|May 21, 2018
A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous CohortsDonna P Ankerst, Johanna Straubinger, Katharina Selig, et al.
Pageof 22

Showing results (161-170 of 214) with videos related to

Sort By:
Pageof 22
BJU International|April 13, 2007
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancerAndrea Gallina, Pierre I Karakiewicz, Felix K-H Chun, et al.
Plos One|August 1, 2015
High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate CancerNathaniel Melling, Levon Harutyunyan, Claudia Hube-Magg, et al.
BJU International|August 19, 2014
Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre European prospective studyAlberto Abrate, Massimo Lazzeri, Giovanni Lughezzani, et al.
BJU International|October 13, 2006
Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patientsFelix K-H Chun, Alberto Briganti, Elie Antebi, et al.
European Urology|October 3, 2006
Development and external validation of an extended 10-core biopsy nomogramFelix K-H Chun, Alberto Briganti, Markus Graefen, et al.
European Urology|September 20, 2015
Safer Surgery by Learning from Complications: A Focus on Robotic Prostate SurgeryRené J Sotelo, Alexander Haese, Victor Machuca, et al.
Cancer Biology & Medicine|February 25, 2021
Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancerAndreas Marx, Lena Koopmann, Doris Höflmayer, et al.
BJU International|September 16, 2009
Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancerHendrik Isbarn, Pierre I Karakiewicz, Sascha A Ahyai, et al.
European Urology|October 4, 2025
Best Systemic Therapy With or Without Radical Prostatectomy in the Management of Men With Oligometastatic Prostate Cancer: The RAMPP Randomised Controlled TrialMarkus Graefen, Fabian Falkenbach, Tobias Maurer, et al.
European Urology|May 21, 2018
A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous CohortsDonna P Ankerst, Johanna Straubinger, Katharina Selig, et al.
Pageof 22